Elevate Your Game with the Rosh Internal Medicine Buzz Exam 2026 – Ace It Like a Pro!

In managing acute exacerbations of asthma, it's crucial to avoid medications that can worsen bronchospasm. Beta-blockers fall into this category. While they are used for a variety of cardiovascular conditions, non-selective beta-blockers can antagonize the effects of beta-2 adrenergic agonists, which are commonly used as rescue medications for asthma attacks. This can lead to increased airway resistance and further complicate the acute exacerbation, thereby worsening the patient's respiratory status.

On the other hand, leukotriene modifiers and corticosteroids actually play a role in treating acute exacerbations. Corticosteroids help reduce inflammation in the airways and can be crucial in managing severe asthma attacks. Anticholinergics may provide additional bronchodilation in acute settings and are often used alongside other medications in these scenarios. Thus, beta-blockers are specifically contraindicated in this context due to their potential to exacerbate the condition.